Maurizia Rossana Brunetto

Statements from the Taormina expert meeting on occult hepatitis B virus infection

Giovanni Raimondo, Jean‐Pierre Allain, Maurizia Rossana Brunetto et al. · Journal of Hepatology · 2008 · 823 citations

Medicine, Infectious Diseases, Internal Medicine +9

Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

B. Coco, Filippo Oliveri, A.M. Maina et al. · Journal of Viral Hepatitis · 2006 · 656 citations

Medicine, Internal Medicine, Pathology +17

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Edward Gane, Wai Kay Seto, Henry Lik‐Yuen Chan et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 546 citations

Pharmacy, Infectious Diseases, Pharmacology +12

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # †

Maurizia Rossana Brunetto, F. Moriconi, Ferruccio Bonino et al. · Hepatology · 2008 · 483 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12